hydroxychloroquine has been researched along with Depression in 9 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study included 105 patients with rheumatoid arthritis who were treated with methotrexate, leflunomide, hydroxychloroquine and biological drugs." | 7.79 | Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. ( Nardi, AE; Ornelas, AC; Pinho de Oliveira Ribeiro, N; Pinho de Oliveira, CM; Rafael de Mello Schier, A; Silva, AC, 2013) |
| "The study included 105 patients with rheumatoid arthritis who were treated with methotrexate, leflunomide, hydroxychloroquine and biological drugs." | 3.79 | Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. ( Nardi, AE; Ornelas, AC; Pinho de Oliveira Ribeiro, N; Pinho de Oliveira, CM; Rafael de Mello Schier, A; Silva, AC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Shader, RI | 2 |
| Lane, JCE | 1 |
| Weaver, J | 1 |
| Kostka, K | 1 |
| Duarte-Salles, T | 1 |
| Abrahao, MTF | 1 |
| Alghoul, H | 1 |
| Alser, O | 1 |
| Alshammari, TM | 1 |
| Areia, C | 1 |
| Biedermann, P | 1 |
| Banda, JM | 1 |
| Burn, E | 1 |
| Casajust, P | 1 |
| Fister, K | 1 |
| Hardin, J | 1 |
| Hester, L | 1 |
| Hripcsak, G | 1 |
| Kaas-Hansen, BS | 1 |
| Khosla, S | 1 |
| Kolovos, S | 1 |
| Lynch, KE | 1 |
| Makadia, R | 1 |
| Mehta, PP | 1 |
| Morales, DR | 1 |
| Morgan-Stewart, H | 1 |
| Mosseveld, M | 1 |
| Newby, D | 1 |
| Nyberg, F | 1 |
| Ostropolets, A | 1 |
| Woong Park, R | 1 |
| Prats-Uribe, A | 1 |
| Rao, GA | 1 |
| Reich, C | 1 |
| Rijnbeek, P | 1 |
| Sena, AG | 1 |
| Shoaibi, A | 1 |
| Spotnitz, M | 1 |
| Subbian, V | 1 |
| Suchard, MA | 1 |
| Vizcaya, D | 1 |
| Wen, H | 1 |
| Wilde, M | 1 |
| Xie, J | 1 |
| You, SC | 1 |
| Zhang, L | 1 |
| Lovestone, S | 1 |
| Ryan, P | 1 |
| Prieto-Alhambra, D | 1 |
| Nguyen, T | 1 |
| Reveley, C | 1 |
| Pinho de Oliveira Ribeiro, N | 1 |
| Rafael de Mello Schier, A | 1 |
| Ornelas, AC | 1 |
| Pinho de Oliveira, CM | 1 |
| Nardi, AE | 1 |
| Silva, AC | 1 |
| MCDUFFIE, FC | 1 |
| Wiggli, S | 1 |
| Lüthy, J | 1 |
| Tyndall, A | 1 |
| Vogt, T | 1 |
| Nashel, DJ | 1 |
| Ulmer, CC | 1 |
| Van Horn, G | 1 |
| Arnett, FC | 1 |
| Dimachkie, MM | 1 |
| Good, MI | 1 |
1 review available for hydroxychloroquine and Depression
| Article | Year |
|---|---|
Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives.
Topics: Adult; Aged; Amodiaquine; Behavior; Chloroquine; Consciousness; Delirium; Depression; Female; Humans | 1977 |
8 other studies available for hydroxychloroquine and Depression
| Article | Year |
|---|---|
COVID-19 and Depression.
Topics: Anxiety; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Depression; Humans; Hydroxy | 2020 |
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; COVID-19 Drug | 2021 |
Intentional overdose in an adolescent with depression: Important considerations when prescribing for adolescents.
Topics: Adolescent; Combined Modality Therapy; Depression; Directive Counseling; Drug Overdose; Emergency Se | 2019 |
Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs.
Topics: Adult; Aged; Antirheumatic Agents; Anxiety; Arthritis, Rheumatoid; Comorbidity; Depression; Female; | 2013 |
BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Topics: Adolescent; Agranulocytosis; Anemia; Anemia, Aplastic; Anti-Bacterial Agents; Bone Marrow; Bone Marr | 1965 |
[Pericardial effusion in a 21-year-old employee].
Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents; Antirheumatic Agents; Autoantibodies; Depres | 2006 |
Systemic lupus erythematosus: important considerations in the adolescent.
Topics: Adolescent; Alopecia; Anxiety; Chronic Disease; Depression; Female; Humans; Hydroxychloroquine; Lupu | 1982 |
Reversible dementia and chorea in a young woman with the lupus anticoagulant.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Chorea; Dementia; Depression; Diagno | 1996 |